Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Top Upgrades
- Susquehanna upgraded Helmerich & Payne, Inc. (NYSE:HP) from Neutral to Positive. Helmerich & Payne shares fell 0.15 percent to close at $65.02 on Thursday.
- JP Morgan upgraded Commercial Metals Company (NYSE:CMC) from Neutral to Overweight. Commercial Metals shares fell 3.56 percent to close at $25.20 on Thursday.
- Gabelli & Co. upgraded Navistar International Corp (NYSE:NAV) from Hold to Buy. Navistar shares rose 3.05 percent to close at $38.17 on Thursday.
- Analysts at JMP Securities upgraded Kennedy-Wilson Holdings Inc (NYSE:KW) from Market Perform to Market Outperform. Kennedy-Wilson rose 0.89 percent to close at $17.00 on Thursday.
- BTIG Research upgraded Nutanix Inc (NASDAQ:NTNX) from Neutral to Buy. Nutanix shares rose 2.76 percent to $47.60 in pre-market trading.
- Cowen & Co. upgraded Kohl's Corporation (NYSE:KSS) from Market Perform to Outperform. Kohl's shares rose 0.98 percent to $62.80 in pre-market trading.
- JP Morgan upgraded Akamai Technologies, Inc. (NASDAQ:AKAM) from Neutral to Overweight. Akamai shares rose 1.89 percent to $76.50 in pre-market trading.
- Analysts at Mizuho upgraded Concert Pharmaceuticals Inc (NASDAQ:CNCE) from Neutral to Buy. Concert Pharmaceuticals shares rose 0.14 percent to close at $22.12 on Thursday.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Top Downgrades
- Analysts at Wells Fargo downgraded Match Group Inc (NASDAQ:MTCH) from Outperform to Market Perform. Match Group shares fell 1.94 percent to $43.50 in pre-market trading.
- JP Morgan downgraded Fortive Corp (NYSE:FTV) from Overweight to Neutral. Fortive shares fell 0.63 percent to $77.87 in pre-market trading.
- B. Riley downgraded Autoweb Inc (NASDAQ:AUTO) from Buy to Neutral. AutoWeb shares fell 34.37 percent to $4.45 in pre-market trading.
- Needham downgraded Finisar Corporation (NASDAQ:FNSR) from Buy to Hold. Finisar shares fell 10.48 percent to $18.10 in pre-market trading.
- Credit Suisse downgraded Ranger Energy Services Inc (NYSE:RNGR) from Outperform to Neutral. Ranger Energy shares fell 1.36 percent to close at $8.71 on Thursday.
- Piper Jaffray downgraded Insys Therapeutics Inc (NASDAQ:INSY) from Neutral to Underweight. Insys Therapeutics shares declined 10.69 percent to $6.85 in pre-market trading.
- SunTrust Robinson Humphrey downgraded SL Green Realty Corp (NYSE:SLG) from Buy to Hold. SL Green Realty shares fell 0.61 percent to close at $99.47 on Thursday.
- Morgan Stanley downgraded Acacia Communications, Inc. (NASDAQ:ACIA) from Equal-Weight to Underweight. Acacia Communications shares dropped 3.97 percent to $40.37 in pre-market trading.
- Chardan Capital downgraded Vascular Biogenics Ltd (NASDAQ:VBLT) from Buy to Neutral. Vascular Biogenics shares fell 1.89 percent to $2.60 in pre-market trading.
- Keefe Bruyette & Woods downgraded XL Group Ltd. (NYSE:XL) from Outperform to Market Perform. XL Group shares rose 0.09 percent to close at $55.80 on Thursday.
Top Initiations
- RBC Capital initiated coverage on Proteostasis Therapeutics Inc (NASDAQ:PTI) with an Outperform rating. The price target for Proteostasis Therapeutics is set to $11. Proteostasis Therapeutics shares closed at $3.61 on Thursday.
- Wells Fargo initiated coverage on Endocyte, Inc. (NASDAQ:ECYT) with an Outperform rating. The price target for Endocyte is set to $20. Endocyte shares closed at $8.06 on Thursday.
- Evercore ISI Group initiated coverage on Miragen Therapeutics, Inc. (NASDAQ:MGEN) with an Outperform rating. The price target for Miragen Therapeutics is set to $19. Miragen Therapeutics shares closed at $6.44 on Thursday.
- Bernstein initiated coverage on Kroger Co (NYSE:KR) with a Market Perform rating. The price target for Kroger is set to $27. Kroger shares closed at $22.98 on Thursday.
- Cowen & Co initiated coverage on Rocket Pharmaceuticals Inc (NASDAQ:RCKT) with an Outperform rating. Rocket Pharmaceuticals shares closed at $17.97 on Thursday.
- Analysts at DA Davidson initiated coverage on Hortonworks Inc (NASDAQ:HDP) with a Buy rating. The price target for Hortonworks is set to $24. Hortonworks shares closed at $20.44 on Thursday.
- Analysts at Piper Jaffray initiated coverage on Ovid Therapeutics Inc (NASDAQ:OVID) with an Overweight rating. The price target for Ovid Therapeutics is set to $20. Ovid Therapeutics closed at $8.00 on Thursday.
- Analysts at Morgan Stanley initiated coverage on Finisar Corporation (NASDAQ:FNSR) with an Equal-Weight rating. The price target for Finisar is set to $21. Finisar shares closed at $20.22 on Thursday.
- Stifel Nicolaus initiated coverage on Nutanix Inc (NASDAQ:NTNX) with a Buy rating. The price target for Nutanix is set to $52. Nutanix shares closed at $46.32 on Thursday.
- Analysts at Loop Capital initiated coverage on Urban Outfitters, Inc. (NASDAQ:URBN) with a Buy rating. The price target for Urban Outfitters is set to $46. Urban Outfitters closed at $35.13 on Thursday.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.